Sylvia Cheung | CFO |
Charles Sherwood | CEO |
Joe Munda | First Analysis |
Jim Sidoti | Sidoti & Company |
Mike Petusky | Barrington Research |
Good day, ladies and gentlemen, and welcome to the Anika Therapeutics' Fourth Quarter and Full-Year 2017 Earnings Conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions]. I would now like to turn the call over to Sylvia Cheung, Chief Financial Officer.